Healthcare Resource Utilization for Patients Undergoing Autologous Stem Cell Transplantation: Identification of Cost Drivers

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.320 ◽

2018 ◽

Vol 24 (3) ◽

pp. S311

Author(s):

Miranda Blanco ◽

Christian A. Gordillo ◽

Markus Y. Mapara ◽

Prakash Satwani ◽

Ran Reshef

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Resource Utilization ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Download Full-text

Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost

International Journal of Hematology ◽

10.1007/s12185-020-03022-5 ◽

2020 ◽

Author(s):

Shinsuke Iida ◽

Tadao Ishida ◽

Katsuhisa Horimoto ◽

Hirotaka Kazama ◽

Hyunchung Kim ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Resource Utilization ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Medical Database ◽

Database Analysis

Download Full-text

Healthcare Resource Utilisation and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients Who Did Not Undergo Autologous Stem Cell Transplantation: Trends in Sweden with the Changing Treatment Landscape

European Journal Of Haematology ◽

10.1111/ejh.13623 ◽

2021 ◽

Author(s):

Fredrik Borgsten ◽

Xenia Gatopoulou ◽

Marta Pisini ◽

Magnus Tambour ◽

Frida Schain ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Sickness Absence ◽

Autologous Stem Cell Transplantation ◽

Healthcare Resource ◽

Resource Utilisation ◽

Newly Diagnosed ◽

Healthcare Resource Utilisation

Download Full-text

Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimens

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1924369 ◽

2021 ◽

pp. 1-10

Author(s):

Elena Zamagni ◽

Sujith Dhanasiri ◽

Arun Ghale ◽

Adam Moore ◽

Murielle Roussel

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Treatment Outcomes ◽

Resource Utilization ◽

Healthcare Resource ◽

Patient Characteristics ◽

Healthcare Resource Utilization ◽

Newly Diagnosed

Download Full-text

Cancer Research Highlights: High-Dose Chemo Plus Autologous Stem Cell Transplantation Boosts Event-Free Survival in Some Patients with Aggressive NHL

PsycEXTRA Dataset ◽

10.1037/e364142004-008 ◽

2004 ◽

Author(s):

Keyword(s):

Cancer Research ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Event Free Survival ◽

Download Full-text

Decision letter for "Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels"

10.1002/hon.2774/v2/decision1 ◽

2020 ◽

Keyword(s):

Vitamin D ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Download Full-text

Review for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/review1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/decision1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era"

10.1002/hon.2713/v1/decision1 ◽

2019 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Follicular Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Clinical Characteristics

Download Full-text

Faculty Opinions recommendation of Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108297.564322 ◽

2008 ◽

Author(s):

Xavier Leleu

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Plasma Cell ◽

Plasma Cell Disorders

Download Full-text

Faculty Opinions recommendation of A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995302.793474247 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase 1 ◽

Download Full-text